MiNK Therapeutics Statistics
Total Valuation
INKT has a market cap or net worth of $31.76 million. The enterprise value is $28.39 million.
| Market Cap | 31.76M |
| Enterprise Value | 28.39M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
INKT has 34.70 million shares outstanding. The number of shares has increased by 2.04% in one year.
| Shares Outstanding | 34.70M |
| Shares Change (YoY) | +2.04% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 71.34% |
| Owned by Institutions (%) | 2.99% |
| Float | 10.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.32
| Current Ratio | 0.32 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -220.60% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$724,447 |
| Employee Count | 31 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.58% in the last 52 weeks. The beta is 0.12, so INKT's price volatility has been lower than the market average.
| Beta (1Y) | 0.12 |
| 52-Week Price Change | -58.58% |
| 50-Day Moving Average | 0.96 |
| 200-Day Moving Average | 1.19 |
| Relative Strength Index (RSI) | 45.53 |
| Average Volume (30 Days) | 99,416 |
Short Selling Information
The latest short interest is 41,095, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 41,095 |
| Short Previous Month | 46,459 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.41% |
| Short Ratio (days to cover) | 0.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -22.92M |
| Pretax Income | -22.46M |
| Net Income | -22.46M |
| EBITDA | -22.25M |
| EBIT | -22.46M |
| Earnings Per Share (EPS) | -$0.65 |
Balance Sheet
The company has $3.37 million in cash and no debt, giving a net cash position of $3.37 million or $0.10 per share.
| Cash & Cash Equivalents | 3.37M |
| Total Debt | n/a |
| Net Cash | 3.37M |
| Net Cash Per Share | $0.10 |
| Equity / Book Value | -18.06M |
| Book Value Per Share | -0.52 |
| Working Capital | -7.80M |
Cash Flow
In the last 12 months, operating cash flow was -$15.76 million and capital expenditures -$73,561, giving a free cash flow of -$15.84 million.
| Operating Cash Flow | -15.76M |
| Capital Expenditures | -73,561 |
| Free Cash Flow | -15.84M |
| FCF Per Share | -$0.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INKT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.04% |
| Shareholder Yield | -2.04% |
| Earnings Yield | -70.71% |
| FCF Yield | -49.86% |
Analyst Forecast
The average price target for INKT is $9.00, which is 883.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.00 |
| Price Target Difference | 883.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |